2-YEARS EXPERIENCE WITH PACLITAXEL/CARBO- PLATIN AS FIRST LINE THERAPY IN METASTATIC BLADDER CANCER

MLA

Bernd Posch, et al. “2-Years Experience with Paclitaxel/Carbo- Platin as First Line Therapy in Metastatic Bladder Cancer.” The Journal of Urology, Apr. 1999, p. 263. EBSCOhost, https://doi.org/10.1097/00005392-199904020-00055.

APA

Bernd Posch, B. Schnack, Ch. Zielinski, Armin Pycha, Gertraud Heinz-Peer, M. Grbovic, & Michael Marberger. (1999). 2-Years Experience with Paclitaxel/Carbo- Platin as First Line Therapy in Metastatic Bladder Cancer. The Journal of Urology, 263. https://doi.org/10.1097/00005392-199904020-00055

Chicago

Bernd Posch, B. Schnack, Ch. Zielinski, Armin Pycha, Gertraud Heinz-Peer, M. Grbovic, and Michael Marberger. 1999. “2-Years Experience with Paclitaxel/Carbo- Platin as First Line Therapy in Metastatic Bladder Cancer.” The Journal of Urology, April, 263. doi:10.1097/00005392-199904020-00055.